Overview

Lovastatin as a Potential Modulator of Apoptosis in Chronic Obstructive Pulmonary Disease (COPD)

Status:
Completed
Trial end date:
2012-11-01
Target enrollment:
Participant gender:
Summary
This study will test whether lovastatin helps to modify lung inflammation in patients with COPD (Chronic Obstructive Pulmonary Disease).
Phase:
Phase 2
Details
Lead Sponsor:
National Jewish Health
Collaborator:
National Heart, Lung, and Blood Institute (NHLBI)
Treatments:
Dihydromevinolin
L 647318
Lovastatin